Clinical efficacy of dupilumab in the treatment of severe chronic rhinosinusitis: The first case outside of a clinical trial

Treatment options for severe CRSwNP are limited. Dupilumab is a safe, well‐tolerated, and effective alternative in patients with poor control of symptoms, corticosteroid‐dependent disease, and high rates of recurrence of nasal polyps after surgery.

Detalles Bibliográficos
Autores principales: Trimarchi, Matteo, Indelicato, Pietro, Vinciguerra, Alessandro, Bussi, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981721/
https://www.ncbi.nlm.nih.gov/pubmed/33768860
http://dx.doi.org/10.1002/ccr3.3792
_version_ 1783667572618559488
author Trimarchi, Matteo
Indelicato, Pietro
Vinciguerra, Alessandro
Bussi, Mario
author_facet Trimarchi, Matteo
Indelicato, Pietro
Vinciguerra, Alessandro
Bussi, Mario
author_sort Trimarchi, Matteo
collection PubMed
description Treatment options for severe CRSwNP are limited. Dupilumab is a safe, well‐tolerated, and effective alternative in patients with poor control of symptoms, corticosteroid‐dependent disease, and high rates of recurrence of nasal polyps after surgery.
format Online
Article
Text
id pubmed-7981721
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-79817212021-03-24 Clinical efficacy of dupilumab in the treatment of severe chronic rhinosinusitis: The first case outside of a clinical trial Trimarchi, Matteo Indelicato, Pietro Vinciguerra, Alessandro Bussi, Mario Clin Case Rep Case Reports Treatment options for severe CRSwNP are limited. Dupilumab is a safe, well‐tolerated, and effective alternative in patients with poor control of symptoms, corticosteroid‐dependent disease, and high rates of recurrence of nasal polyps after surgery. John Wiley and Sons Inc. 2021-01-16 /pmc/articles/PMC7981721/ /pubmed/33768860 http://dx.doi.org/10.1002/ccr3.3792 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Trimarchi, Matteo
Indelicato, Pietro
Vinciguerra, Alessandro
Bussi, Mario
Clinical efficacy of dupilumab in the treatment of severe chronic rhinosinusitis: The first case outside of a clinical trial
title Clinical efficacy of dupilumab in the treatment of severe chronic rhinosinusitis: The first case outside of a clinical trial
title_full Clinical efficacy of dupilumab in the treatment of severe chronic rhinosinusitis: The first case outside of a clinical trial
title_fullStr Clinical efficacy of dupilumab in the treatment of severe chronic rhinosinusitis: The first case outside of a clinical trial
title_full_unstemmed Clinical efficacy of dupilumab in the treatment of severe chronic rhinosinusitis: The first case outside of a clinical trial
title_short Clinical efficacy of dupilumab in the treatment of severe chronic rhinosinusitis: The first case outside of a clinical trial
title_sort clinical efficacy of dupilumab in the treatment of severe chronic rhinosinusitis: the first case outside of a clinical trial
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981721/
https://www.ncbi.nlm.nih.gov/pubmed/33768860
http://dx.doi.org/10.1002/ccr3.3792
work_keys_str_mv AT trimarchimatteo clinicalefficacyofdupilumabinthetreatmentofseverechronicrhinosinusitisthefirstcaseoutsideofaclinicaltrial
AT indelicatopietro clinicalefficacyofdupilumabinthetreatmentofseverechronicrhinosinusitisthefirstcaseoutsideofaclinicaltrial
AT vinciguerraalessandro clinicalefficacyofdupilumabinthetreatmentofseverechronicrhinosinusitisthefirstcaseoutsideofaclinicaltrial
AT bussimario clinicalefficacyofdupilumabinthetreatmentofseverechronicrhinosinusitisthefirstcaseoutsideofaclinicaltrial

Ejemplares similares